

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.72463888 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.72463888 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.39353487 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.26029703 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 4.89327242 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.81688081 |
| 7 | type I interferon signaling pathway (GO:0060337) | 4.72757800 |
| 8 | cellular response to type I interferon (GO:0071357) | 4.72757800 |
| 9 | response to type I interferon (GO:0034340) | 4.69341950 |
| 10 | regulation of interferon-alpha production (GO:0032647) | 4.62750324 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.58643436 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.58643436 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.56983055 |
| 14 | response to interleukin-15 (GO:0070672) | 4.56817187 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.52965163 |
| 16 | positive thymic T cell selection (GO:0045059) | 4.52835436 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 4.43672422 |
| 18 | response to peptidoglycan (GO:0032494) | 4.32929961 |
| 19 | regulation of RIG-I signaling pathway (GO:0039535) | 4.31830983 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.24176793 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.21533271 |
| 22 | positive T cell selection (GO:0043368) | 4.12661748 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.08792124 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 4.07681965 |
| 25 | thymic T cell selection (GO:0045061) | 4.01792468 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.98722481 |
| 27 | positive regulation of interleukin-12 production (GO:0032735) | 3.95347711 |
| 28 | cellular response to exogenous dsRNA (GO:0071360) | 3.94756864 |
| 29 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.94101343 |
| 30 | cellular response to zinc ion (GO:0071294) | 3.92523673 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.89120182 |
| 32 | T cell selection (GO:0045058) | 3.88920833 |
| 33 | negative regulation of viral genome replication (GO:0045071) | 3.87012367 |
| 34 | detection of other organism (GO:0098543) | 3.86246369 |
| 35 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.81776165 |
| 36 | detection of bacterium (GO:0016045) | 3.81185734 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.78199109 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.78199109 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.78199109 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.78199109 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.78199109 |
| 42 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.78199109 |
| 43 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.77816085 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.77602785 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76646958 |
| 46 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.74096356 |
| 47 | neutrophil activation (GO:0042119) | 3.73528419 |
| 48 | positive regulation of type 2 immune response (GO:0002830) | 3.72124038 |
| 49 | granulocyte activation (GO:0036230) | 3.68669401 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.68279758 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66249514 |
| 52 | NIK/NF-kappaB signaling (GO:0038061) | 3.66053383 |
| 53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.65797159 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.65391592 |
| 55 | defense response to protozoan (GO:0042832) | 3.62967031 |
| 56 | cellular response to interferon-beta (GO:0035458) | 3.62281289 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.60426617 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 3.60389490 |
| 59 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.60174770 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.59773265 |
| 61 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.56780022 |
| 62 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.54552335 |
| 63 | natural killer cell mediated immunity (GO:0002228) | 3.54552335 |
| 64 | T-helper 1 type immune response (GO:0042088) | 3.53844644 |
| 65 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.53739849 |
| 66 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.53134669 |
| 67 | response to interferon-alpha (GO:0035455) | 3.51932773 |
| 68 | regulation of T cell tolerance induction (GO:0002664) | 3.51354616 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.51183358 |
| 70 | cellular response to virus (GO:0098586) | 3.50482550 |
| 71 | myeloid dendritic cell activation (GO:0001773) | 3.47538607 |
| 72 | negative regulation of B cell proliferation (GO:0030889) | 3.45956802 |
| 73 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.45742330 |
| 74 | cytidine metabolic process (GO:0046087) | 3.44450486 |
| 75 | cytidine catabolic process (GO:0006216) | 3.44450486 |
| 76 | cytidine deamination (GO:0009972) | 3.44450486 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 3.44101993 |
| 78 | respiratory burst (GO:0045730) | 3.42333076 |
| 79 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.39504797 |
| 80 | leukocyte aggregation (GO:0070486) | 3.38407581 |
| 81 | T cell migration (GO:0072678) | 3.37202331 |
| 82 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37107680 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.36676173 |
| 84 | tolerance induction (GO:0002507) | 3.36247503 |
| 85 | positive regulation of humoral immune response (GO:0002922) | 3.34293122 |
| 86 | B cell proliferation (GO:0042100) | 3.33168618 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30954329 |
| 88 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.30641798 |
| 89 | detection of external biotic stimulus (GO:0098581) | 3.29597109 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28802641 |
| 91 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.28297873 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 3.27688198 |
| 93 | response to interferon-beta (GO:0035456) | 3.27002755 |
| 94 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.26881004 |
| 95 | negative thymic T cell selection (GO:0045060) | 3.25092221 |
| 96 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.24979417 |
| 97 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.24979417 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 3.24966112 |
| 99 | B cell homeostasis (GO:0001782) | 3.22986688 |
| 100 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22724421 |
| 101 | interferon-gamma production (GO:0032609) | 3.21946217 |
| 102 | B cell mediated immunity (GO:0019724) | 3.19872583 |
| 103 | positive regulation of granulocyte differentiation (GO:0030854) | 3.19743771 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 3.19405309 |
| 105 | dendritic cell chemotaxis (GO:0002407) | 3.19372766 |
| 106 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19181497 |
| 107 | regulation of tolerance induction (GO:0002643) | 3.19118430 |
| 108 | response to protozoan (GO:0001562) | 3.19062325 |
| 109 | T cell costimulation (GO:0031295) | 3.18933385 |
| 110 | regulation of T-helper cell differentiation (GO:0045622) | 3.18064868 |
| 111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.16344343 |
| 112 | positive regulation of interleukin-17 production (GO:0032740) | 3.15375255 |
| 113 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.15320315 |
| 114 | positive regulation of interleukin-2 production (GO:0032743) | 3.15261028 |
| 115 | germinal center formation (GO:0002467) | 3.14448741 |
| 116 | lymphocyte costimulation (GO:0031294) | 3.14364493 |
| 117 | microglial cell activation (GO:0001774) | 3.14188035 |
| 118 | cellular extravasation (GO:0045123) | 3.14111015 |
| 119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.13295646 |
| 120 | regulation of B cell differentiation (GO:0045577) | 3.11508158 |
| 121 | negative regulation of interleukin-17 production (GO:0032700) | 3.09773238 |
| 122 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.09638702 |
| 123 | T cell receptor signaling pathway (GO:0050852) | 3.09389743 |
| 124 | positive regulation of defense response to virus by host (GO:0002230) | 3.09106113 |
| 125 | negative T cell selection (GO:0043383) | 3.06975140 |
| 126 | regulation of B cell proliferation (GO:0030888) | 3.06553270 |
| 127 | myeloid cell activation involved in immune response (GO:0002275) | 3.04847055 |
| 128 | natural killer cell activation (GO:0030101) | 3.03184740 |
| 129 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03069182 |
| 130 | positive regulation of B cell mediated immunity (GO:0002714) | 3.02631533 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.02631533 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 3.02227777 |
| 133 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.01678596 |
| 134 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.01527599 |
| 135 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01402896 |
| 136 | positive regulation of B cell differentiation (GO:0045579) | 3.01158707 |
| 137 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.00656586 |
| 138 | regulation of defense response to virus by host (GO:0050691) | 3.00269493 |
| 139 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.99292010 |
| 140 | leukocyte mediated cytotoxicity (GO:0001909) | 2.98186180 |
| 141 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.97844553 |
| 142 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.97671239 |
| 143 | regulation of interleukin-17 production (GO:0032660) | 2.97589012 |
| 144 | natural killer cell differentiation (GO:0001779) | 2.96499360 |
| 145 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96308828 |
| 146 | response to host immune response (GO:0052572) | 2.96308828 |
| 147 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.96076840 |
| 148 | cellular response to interferon-gamma (GO:0071346) | 2.95835424 |
| 149 | positive regulation of isotype switching (GO:0045830) | 2.93678272 |
| 150 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93136211 |
| 151 | positive regulation of T cell cytokine production (GO:0002726) | 2.92825950 |
| 152 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.91616220 |
| 153 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91421260 |
| 154 | regulation of T-helper 1 type immune response (GO:0002825) | 2.89907042 |
| 155 | macrophage activation involved in immune response (GO:0002281) | 2.88608366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.81194064 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.70641231 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.65500786 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.59600615 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.88085514 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.24400488 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.98520823 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84802955 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.51190059 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.42906515 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41415775 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19084005 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11620243 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.07394724 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.92611960 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.81717619 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66031805 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37528535 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.28791418 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21969457 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.13411066 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.04295773 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.03344599 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96853592 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 1.91524130 |
| 26 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.88639400 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85594872 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84311404 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73211774 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70456793 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69463048 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.66747728 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64778757 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63886751 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63605325 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63483640 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.62675881 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60947915 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59764336 |
| 40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52114825 |
| 41 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51959636 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50942928 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50007572 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49214193 |
| 45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40864444 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36912894 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34832715 |
| 48 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34723522 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32384498 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.32267833 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31653204 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31185779 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30286008 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29847232 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28513908 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27744152 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26339216 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25526324 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21152193 |
| 60 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18331732 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.17030212 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15726569 |
| 63 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14102864 |
| 64 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10899727 |
| 65 | MAF_26560356_Chip-Seq_TH2_Human | 1.08681617 |
| 66 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08077802 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06030307 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03515063 |
| 69 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02379015 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02370498 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01553915 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01319701 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98511188 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97559230 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96576453 |
| 76 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93403394 |
| 77 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92794967 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92477445 |
| 79 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90877907 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90563934 |
| 81 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84967762 |
| 82 | GATA3_26560356_Chip-Seq_TH1_Human | 0.84247350 |
| 83 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83934758 |
| 84 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.82851723 |
| 85 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82075401 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81932806 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80825371 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79424736 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.77393331 |
| 90 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.75303295 |
| 91 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75264812 |
| 92 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75117881 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74645726 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73632631 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.73571867 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72528191 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.72472731 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72172754 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.71891029 |
| 100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70613272 |
| 101 | * BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69121039 |
| 102 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68654742 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65900982 |
| 104 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65809368 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.65717965 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65028262 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.63865909 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.62554109 |
| 109 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.60490233 |
| 110 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.60000362 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59742458 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 0.57758754 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.57671522 |
| 114 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.56992196 |
| 115 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.55903659 |
| 116 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.55664062 |
| 117 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.55399493 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.55399493 |
| 119 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.55281397 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54998348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.51977903 |
| 2 | MP0009785_altered_susceptibility_to | 4.09426293 |
| 3 | MP0000685_abnormal_immune_system | 3.93009755 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.74154202 |
| 5 | MP0001790_abnormal_immune_system | 3.70628948 |
| 6 | MP0005387_immune_system_phenotype | 3.70628948 |
| 7 | MP0005671_abnormal_response_to | 3.55615632 |
| 8 | MP0001800_abnormal_humoral_immune | 3.44925004 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.36074230 |
| 10 | MP0003436_decreased_susceptibility_to | 3.28441294 |
| 11 | MP0005025_abnormal_response_to | 3.18129886 |
| 12 | MP0002452_abnormal_antigen_presenting | 3.12619429 |
| 13 | MP0002723_abnormal_immune_serum | 3.00578836 |
| 14 | MP0006082_CNS_inflammation | 2.92534544 |
| 15 | MP0002419_abnormal_innate_immunity | 2.86715976 |
| 16 | MP0001819_abnormal_immune_cell | 2.70665014 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.67001321 |
| 18 | MP0004510_myositis | 2.62860229 |
| 19 | MP0003724_increased_susceptibility_to | 2.58341066 |
| 20 | MP0003303_peritoneal_inflammation | 2.38131370 |
| 21 | MP0002398_abnormal_bone_marrow | 2.20198750 |
| 22 | MP0000716_abnormal_immune_system | 2.15104077 |
| 23 | MP0001853_heart_inflammation | 2.00132015 |
| 24 | MP0002006_tumorigenesis | 1.99889960 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.98068639 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.96072575 |
| 27 | MP0002405_respiratory_system_inflammati | 1.93382659 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.92318684 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.86344243 |
| 30 | MP0005310_abnormal_salivary_gland | 1.83798616 |
| 31 | MP0009764_decreased_sensitivity_to | 1.82962966 |
| 32 | MP0004947_skin_inflammation | 1.80533319 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.75140195 |
| 34 | MP0002429_abnormal_blood_cell | 1.73638978 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.73538342 |
| 36 | MP0002722_abnormal_immune_system | 1.63330029 |
| 37 | MP0008469_abnormal_protein_level | 1.61975793 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.59238317 |
| 39 | MP0004381_abnormal_hair_follicle | 1.53393041 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.43235964 |
| 41 | MP0002396_abnormal_hematopoietic_system | 1.40388147 |
| 42 | MP0008260_abnormal_autophagy | 1.37373889 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.36674730 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.36674730 |
| 45 | MP0005451_abnormal_body_composition | 1.35776494 |
| 46 | MP0000343_altered_response_to | 1.33468224 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.33123720 |
| 48 | MP0003448_altered_tumor_morphology | 1.31701781 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.26045478 |
| 50 | MP0001873_stomach_inflammation | 1.23063608 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.21383330 |
| 52 | MP0000858_altered_metastatic_potential | 1.20324667 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.18857458 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.15151582 |
| 55 | MP0009278_abnormal_bone_marrow | 1.11459908 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.09101911 |
| 57 | MP0002009_preneoplasia | 1.07009875 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.01318502 |
| 59 | MP0008057_abnormal_DNA_replication | 0.99474841 |
| 60 | MP0000490_abnormal_crypts_of | 0.99131348 |
| 61 | MP0002163_abnormal_gland_morphology | 0.96328085 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 0.90251212 |
| 63 | MP0004883_abnormal_blood_vessel | 0.89352797 |
| 64 | MP0009763_increased_sensitivity_to | 0.89147023 |
| 65 | MP0002998_abnormal_bone_remodeling | 0.87924196 |
| 66 | MP0003075_altered_response_to | 0.87507685 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.86797196 |
| 68 | MP0005174_abnormal_tail_pigmentation | 0.86507463 |
| 69 | MP0003866_abnormal_defecation | 0.85471888 |
| 70 | MP0002933_joint_inflammation | 0.80727277 |
| 71 | MP0003172_abnormal_lysosome_physiology | 0.80222116 |
| 72 | MP0000015_abnormal_ear_pigmentation | 0.79977120 |
| 73 | MP0010307_abnormal_tumor_latency | 0.79802887 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.78602048 |
| 75 | MP0003693_abnormal_embryo_hatching | 0.78573821 |
| 76 | MP0003045_fibrosis | 0.78294781 |
| 77 | MP0003300_gastrointestinal_ulcer | 0.78139938 |
| 78 | MP0003828_pulmonary_edema | 0.77219416 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.75433048 |
| 80 | MP0005166_decreased_susceptibility_to | 0.73700882 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.72928468 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.72783167 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.71845218 |
| 84 | MP0000371_diluted_coat_color | 0.70722263 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.69288443 |
| 86 | MP0003091_abnormal_cell_migration | 0.69174948 |
| 87 | MP0002254_reproductive_system_inflammat | 0.65191889 |
| 88 | MP0001851_eye_inflammation | 0.64934031 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.64872975 |
| 90 | MP0005390_skeleton_phenotype | 0.64623189 |
| 91 | MP0000249_abnormal_blood_vessel | 0.64403353 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62709968 |
| 93 | MP0003186_abnormal_redox_activity | 0.62420909 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.61713808 |
| 95 | MP0005164_abnormal_response_to | 0.60981353 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.60552861 |
| 97 | MP0002136_abnormal_kidney_physiology | 0.59203095 |
| 98 | MP0003787_abnormal_imprinting | 0.59034378 |
| 99 | MP0009840_abnormal_foam_cell | 0.58131360 |
| 100 | MP0008874_decreased_physiological_sensi | 0.57526821 |
| 101 | MP0000767_abnormal_smooth_muscle | 0.56797197 |
| 102 | MP0003566_abnormal_cell_adhesion | 0.55601092 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.55336851 |
| 104 | MP0000604_amyloidosis | 0.54190283 |
| 105 | MP0002102_abnormal_ear_morphology | 0.53076645 |
| 106 | MP0002132_abnormal_respiratory_system | 0.52593134 |
| 107 | MP0000627_abnormal_mammary_gland | 0.49958927 |
| 108 | MP0001663_abnormal_digestive_system | 0.48253914 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.47685387 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.47084246 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.46647680 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.46516285 |
| 113 | MP0000609_abnormal_liver_physiology | 0.45008597 |
| 114 | MP0003690_abnormal_glial_cell | 0.44278531 |
| 115 | MP0003795_abnormal_bone_structure | 0.42227113 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.41886018 |
| 117 | MP0008004_abnormal_stomach_pH | 0.41641454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.28251944 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.99370530 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.98589343 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.77863128 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.75400154 |
| 6 | Recurrent viral infections (HP:0004429) | 4.73792870 |
| 7 | Autoimmune thrombocytopenia (HP:0001973) | 4.57266115 |
| 8 | Agammaglobulinemia (HP:0004432) | 4.54614008 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.53348814 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.47892300 |
| 11 | Vasculitis (HP:0002633) | 4.40552949 |
| 12 | Increased IgM level (HP:0003496) | 4.36750611 |
| 13 | Chronic otitis media (HP:0000389) | 4.33763895 |
| 14 | Recurrent skin infections (HP:0001581) | 4.29377810 |
| 15 | Myositis (HP:0100614) | 4.26954166 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.18470648 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 4.14184415 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.14184415 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.97659147 |
| 20 | Recurrent bronchitis (HP:0002837) | 3.88986399 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.87348367 |
| 22 | Obstructive lung disease (HP:0006536) | 3.87348367 |
| 23 | Meningitis (HP:0001287) | 3.76226013 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.69735668 |
| 25 | Optic neuritis (HP:0100653) | 3.69735668 |
| 26 | Cellulitis (HP:0100658) | 3.68741315 |
| 27 | Colitis (HP:0002583) | 3.65961193 |
| 28 | Orchitis (HP:0100796) | 3.62747744 |
| 29 | Panhypogammaglobulinemia (HP:0003139) | 3.62683577 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.51334292 |
| 31 | Basal ganglia calcification (HP:0002135) | 3.48416455 |
| 32 | Hypergammaglobulinemia (HP:0010702) | 3.34822449 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 3.25627221 |
| 34 | Abnormality of T cells (HP:0002843) | 3.23324701 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.23207494 |
| 36 | IgG deficiency (HP:0004315) | 3.22626631 |
| 37 | Pustule (HP:0200039) | 3.20018025 |
| 38 | IgA deficiency (HP:0002720) | 3.18847721 |
| 39 | Gingivitis (HP:0000230) | 3.16509839 |
| 40 | Stomatitis (HP:0010280) | 3.16420220 |
| 41 | Recurrent lower respiratory tract infections (HP:0002783) | 3.15289874 |
| 42 | Recurrent pneumonia (HP:0006532) | 3.13048738 |
| 43 | Nasal polyposis (HP:0100582) | 3.09732212 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.07638207 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 3.01188378 |
| 46 | Interstitial pulmonary disease (HP:0006530) | 3.01168740 |
| 47 | IgM deficiency (HP:0002850) | 2.98682771 |
| 48 | Recurrent sinusitis (HP:0011108) | 2.93957330 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.93168717 |
| 50 | Abnormality of T cell number (HP:0011839) | 2.92136197 |
| 51 | Lymphopenia (HP:0001888) | 2.89462452 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.88454915 |
| 53 | Periodontitis (HP:0000704) | 2.85993894 |
| 54 | Osteomyelitis (HP:0002754) | 2.82982479 |
| 55 | Chronic sinusitis (HP:0011109) | 2.81619162 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.80705254 |
| 57 | Leukocytosis (HP:0001974) | 2.74896119 |
| 58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.74214725 |
| 59 | Eosinophilia (HP:0001880) | 2.72107677 |
| 60 | Lymphoma (HP:0002665) | 2.72101676 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.66255782 |
| 62 | Encephalitis (HP:0002383) | 2.63682019 |
| 63 | Thrombocytosis (HP:0001894) | 2.62985044 |
| 64 | Porencephaly (HP:0002132) | 2.53890617 |
| 65 | T lymphocytopenia (HP:0005403) | 2.53657146 |
| 66 | Emphysema (HP:0002097) | 2.51563966 |
| 67 | Thyroiditis (HP:0100646) | 2.50285186 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.48614534 |
| 69 | Petechiae (HP:0000967) | 2.48084376 |
| 70 | Arterial thrombosis (HP:0004420) | 2.48007757 |
| 71 | Chronic diarrhea (HP:0002028) | 2.47509393 |
| 72 | Gangrene (HP:0100758) | 2.47352151 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.44610685 |
| 74 | Pulmonary embolism (HP:0002204) | 2.44501841 |
| 75 | Urticaria (HP:0001025) | 2.42289848 |
| 76 | Epistaxis (HP:0000421) | 2.41553482 |
| 77 | Hemoptysis (HP:0002105) | 2.40639320 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.39315578 |
| 79 | Gingival bleeding (HP:0000225) | 2.39158025 |
| 80 | Viral hepatitis (HP:0006562) | 2.36093200 |
| 81 | Abnormality of eosinophils (HP:0001879) | 2.35117247 |
| 82 | Abnormality of B cell number (HP:0010975) | 2.34575705 |
| 83 | B lymphocytopenia (HP:0010976) | 2.34575705 |
| 84 | Skin rash (HP:0000988) | 2.34507358 |
| 85 | Granulocytopenia (HP:0001913) | 2.33977477 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.31142110 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.29542386 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27141701 |
| 89 | Neutropenia (HP:0001875) | 2.25785283 |
| 90 | Arthralgia (HP:0002829) | 2.20514953 |
| 91 | Acute hepatic failure (HP:0006554) | 2.20110736 |
| 92 | Hypochromic anemia (HP:0001931) | 2.19016301 |
| 93 | Joint swelling (HP:0001386) | 2.18702577 |
| 94 | Abnormality of the prostate (HP:0008775) | 2.18633778 |
| 95 | Sepsis (HP:0100806) | 2.15480135 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.15479925 |
| 97 | Increased IgE level (HP:0003212) | 2.14016529 |
| 98 | Increased cerebral lipofuscin (HP:0011813) | 2.13373336 |
| 99 | Skin ulcer (HP:0200042) | 2.12072594 |
| 100 | Prostate neoplasm (HP:0100787) | 2.11778932 |
| 101 | Recurrent otitis media (HP:0000403) | 2.11176574 |
| 102 | Bronchitis (HP:0012387) | 2.05320060 |
| 103 | Chest pain (HP:0100749) | 2.03687994 |
| 104 | Abnormality of the fingertips (HP:0001211) | 2.03385079 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 2.03314669 |
| 106 | Cleft eyelid (HP:0000625) | 2.02397080 |
| 107 | Amaurosis fugax (HP:0100576) | 2.01830388 |
| 108 | Combined immunodeficiency (HP:0005387) | 2.00487093 |
| 109 | Glomerulopathy (HP:0100820) | 2.00485988 |
| 110 | Restrictive lung disease (HP:0002091) | 1.99966413 |
| 111 | Verrucae (HP:0200043) | 1.99823612 |
| 112 | Papilloma (HP:0012740) | 1.99823612 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.98525402 |
| 114 | Anorexia (HP:0002039) | 1.98489011 |
| 115 | Severe combined immunodeficiency (HP:0004430) | 1.97784300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.52320128 |
| 2 | IRAK4 | 3.74922786 |
| 3 | MAP4K1 | 3.72793859 |
| 4 | TBK1 | 3.53822496 |
| 5 | BLK | 3.42169628 |
| 6 | IKBKE | 3.26722735 |
| 7 | TYK2 | 3.15403383 |
| 8 | IKBKB | 3.01492783 |
| 9 | JAK3 | 3.01412168 |
| 10 | IRAK3 | 2.98181892 |
| 11 | BMPR2 | 2.88736022 |
| 12 | RIPK4 | 2.78217115 |
| 13 | TXK | 2.48992735 |
| 14 | JAK1 | 2.33302378 |
| 15 | MST4 | 2.27770694 |
| 16 | MAP3K13 | 2.22845232 |
| 17 | KIT | 2.20635915 |
| 18 | PRPF4B | 1.98039914 |
| 19 | SYK | 1.95912170 |
| 20 | CHUK | 1.77117976 |
| 21 | BTK | 1.75476005 |
| 22 | ZAP70 | 1.71279215 |
| 23 | PBK | 1.69710478 |
| 24 | PIM2 | 1.61326407 |
| 25 | CSF1R | 1.54800708 |
| 26 | RPS6KA4 | 1.53195899 |
| 27 | PIM1 | 1.49092742 |
| 28 | TEC | 1.44315674 |
| 29 | ERN1 | 1.41550357 |
| 30 | TNK2 | 1.37007884 |
| 31 | CSK | 1.31714084 |
| 32 | STK4 | 1.27512293 |
| 33 | HCK | 1.24737836 |
| 34 | NEK9 | 1.24138367 |
| 35 | STK10 | 1.23891406 |
| 36 | EPHB1 | 1.18978549 |
| 37 | FGFR4 | 1.18473749 |
| 38 | LYN | 1.18037300 |
| 39 | EIF2AK2 | 1.12537837 |
| 40 | LCK | 1.10588385 |
| 41 | IRAK1 | 1.03635213 |
| 42 | PIK3CG | 1.03565028 |
| 43 | ITK | 1.03145041 |
| 44 | FGFR3 | 0.94752395 |
| 45 | TAOK3 | 0.94739183 |
| 46 | SMG1 | 0.92349572 |
| 47 | SIK3 | 0.92210313 |
| 48 | MAP3K10 | 0.89896125 |
| 49 | EPHA3 | 0.85464277 |
| 50 | GRK6 | 0.83068017 |
| 51 | PRKCQ | 0.81708389 |
| 52 | FES | 0.81624877 |
| 53 | JAK2 | 0.80800269 |
| 54 | MARK3 | 0.79566058 |
| 55 | LRRK2 | 0.76865008 |
| 56 | ADRBK2 | 0.76252856 |
| 57 | NLK | 0.72614198 |
| 58 | FLT3 | 0.72556471 |
| 59 | MAP3K5 | 0.68056805 |
| 60 | NME2 | 0.67269191 |
| 61 | MATK | 0.65813548 |
| 62 | IRAK2 | 0.63459383 |
| 63 | MAP3K1 | 0.60742426 |
| 64 | CAMKK2 | 0.59434184 |
| 65 | CDK12 | 0.57824890 |
| 66 | SIK2 | 0.57811081 |
| 67 | MAP3K3 | 0.56405607 |
| 68 | ABL1 | 0.55953617 |
| 69 | CDC42BPA | 0.55876722 |
| 70 | MELK | 0.55630512 |
| 71 | PASK | 0.54972851 |
| 72 | BMX | 0.54737871 |
| 73 | MAPK12 | 0.54459414 |
| 74 | TAOK1 | 0.54104438 |
| 75 | TRPM7 | 0.53380051 |
| 76 | PRKCD | 0.51231867 |
| 77 | MAP3K11 | 0.49072287 |
| 78 | MAPK7 | 0.48167510 |
| 79 | NUAK1 | 0.47456373 |
| 80 | FGR | 0.46184348 |
| 81 | CLK1 | 0.45847148 |
| 82 | TAOK2 | 0.44668545 |
| 83 | CAMKK1 | 0.44268036 |
| 84 | TESK2 | 0.43589229 |
| 85 | TGFBR2 | 0.41813401 |
| 86 | MARK2 | 0.41736315 |
| 87 | KSR2 | 0.39988340 |
| 88 | CDK19 | 0.39230743 |
| 89 | PDPK1 | 0.37585349 |
| 90 | EGFR | 0.37581162 |
| 91 | DMPK | 0.37361254 |
| 92 | PTK2B | 0.36873635 |
| 93 | MAPKAPK2 | 0.36173098 |
| 94 | RPS6KA5 | 0.36123611 |
| 95 | CDK4 | 0.35297363 |
| 96 | ABL2 | 0.33651221 |
| 97 | PRKCH | 0.33239066 |
| 98 | GRK7 | 0.30665221 |
| 99 | MAP2K3 | 0.30377525 |
| 100 | MAP3K7 | 0.29969740 |
| 101 | BRSK2 | 0.29284753 |
| 102 | SGK2 | 0.29159473 |
| 103 | EIF2AK3 | 0.28713559 |
| 104 | WNK1 | 0.28396733 |
| 105 | STK3 | 0.28330021 |
| 106 | ALK | 0.25063998 |
| 107 | GRK5 | 0.24451358 |
| 108 | YES1 | 0.23562120 |
| 109 | HIPK2 | 0.23278037 |
| 110 | PTK6 | 0.23109417 |
| 111 | RPS6KA6 | 0.22696246 |
| 112 | SGK3 | 0.22558626 |
| 113 | TLK1 | 0.22528038 |
| 114 | ATR | 0.22420971 |
| 115 | STK11 | 0.21957461 |
| 116 | MAPK3 | 0.21925522 |
| 117 | PDK1 | 0.21299055 |
| 118 | CDK6 | 0.20240834 |
| 119 | ACVR1B | 0.18573937 |
| 120 | ARAF | 0.18132380 |
| 121 | STK24 | 0.17613565 |
| 122 | GSK3A | 0.16867428 |
| 123 | GRK1 | 0.16730544 |
| 124 | MAPK11 | 0.16491044 |
| 125 | MAP2K6 | 0.13224615 |
| 126 | MAP3K8 | 0.13143520 |
| 127 | PLK4 | 0.11785234 |
| 128 | RPS6KA1 | 0.11339987 |
| 129 | KDR | 0.10331201 |
| 130 | TESK1 | 0.09921147 |
| 131 | FYN | 0.09843150 |
| 132 | EIF2AK1 | 0.09805663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.53267794 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39530004 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.24572923 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02516044 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01692858 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.90993547 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.86000558 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.85497746 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.72016296 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.51965218 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30941471 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.28551047 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17935887 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.11890239 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.11104579 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10698921 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.09017727 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97547567 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.97103299 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.94724330 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.88100308 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.81883253 |
| 23 | Pertussis_Homo sapiens_hsa05133 | 1.79519017 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.77998426 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.76065357 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71512088 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65971185 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63716590 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60698327 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57121588 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.56047372 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54142817 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53607646 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.51656074 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.46051579 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44061814 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34032827 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28691465 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.26254602 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.22454769 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.21431196 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.06995275 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04251156 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89262066 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.88040284 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81820957 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79309387 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79006963 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78887399 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78181303 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76198860 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74909245 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.73800520 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71824856 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70870729 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 0.67509215 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64905262 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64430466 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64150996 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63673935 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.60316949 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59734554 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53735508 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51025520 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49695557 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49582402 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48444346 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47516150 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45777991 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.45015119 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42740221 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 0.42119905 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41093584 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39525376 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37259690 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37223138 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33428548 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33268100 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32864957 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.32757225 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32641239 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32243990 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.31379862 |
| 84 | Homologous recombination_Homo sapiens_hsa03440 | 0.27572719 |
| 85 | DNA replication_Homo sapiens_hsa03030 | 0.26119096 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25652339 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25345967 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24052374 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23585396 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23060283 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.22690148 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22463058 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21803291 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21509029 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21257732 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20650196 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.19244267 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17850035 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.17669074 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16568155 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15971648 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.15803173 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15761564 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15112126 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13268190 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.12858335 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.12435954 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12361477 |
| 109 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11162757 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11158229 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.08561405 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07735062 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07214526 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.06431331 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.05836787 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.05699437 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.05156320 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.04938889 |

